-
There are several reasons the IUD tops the list. IUDs are effective, safe, convenient, cost effective, and fully reversible.
-
Increasing access to HIV testing is a prevention priority in the United States. Health officials estimate more than 25% of those infected are transmitting HIV to others because they are unaware that they are infected.
-
The next woman in your examination room has been using oral contraceptives (OCs) as her chosen method of birth control for the past three months. During her checkup, she tells you that she often misses a pill in her pack, but doesnt take further precautions for protection.
-
Readers of Contraceptive Technology Update who have recently subscribed or renewed their previous subscription have a free gift waiting. As a special bonus, CTU is offering free on-line reports to subscribers.
-
A just-published report in the New England Journal of Medicine (NEJM) finds that the deaths of four California women who took the abortion drug Mifeprex (mifepristone, Danco Laboratories, New York City) were linked to toxic shock caused by the bacterium Clostridium sordellii, but the risk of infection in conjunction with taking the drug is low, state epidemiologists who reviewed the cases.
-
Results from a just-published study indicate that consistent use of condoms is associated with lower rates of infection with herpes simplex virus-2 (HSV-2) and should be routinely recommended.
-
Findings from a new study indicate that use of oral contraceptives (OCs) may affect the development of multiple sclerosis (MS).
-
How much do you know about natural methods of family planning? While such options may be exactly what some women are seeking, many providers don't learn about them during their medical training.
-
Your next patient is a 17-year-old female who is seeking contraception for pregnancy prevention. She is not sure if she wants to take the Pill, and says she's leery of wearing a contraceptive patch. What options can you offer her?
-
One of the final barriers to availability of emergency contraception (EC) has been toppled with the Food and Drug Administration (FDA) approval of nonprescription sales of the EC drug, Plan B. The drug is manufactured by Barr Pharmaceuticals of Pomona, NY, and marketed by its Duramed subsidiary.